Facilitating H. pylori Diagnostics

Helicobacter pylori – 50% of the world’s population is infected

The sooner it is detected, the more treatable it is.
Helicobacter pylori is a gram-negative bacterium that colonizes the gastric mucosa in approximately 50% of the human population. It is one of the most common infectious diseases worldwide and has been classified as a type-1 carcinogen by the WHO (World Health Organization) and IARC (International Agency for Research on Cancer).

Diagnosing and treating the infection early on lowers the risk of developing serious stomach diseases such as peptic ulcers, gastric MALT lymphoma and gastric cancer, which is one of the most common causes of cancer deaths worldwide, with an estimated 1million new cases every year (IARC Factsheet).

Studies show that around 20% to 30% of infected individuals may develop peptic ulcer disease, while the risk for gastric carcinoma increases by a factor of 2 to 35.

Therefore, when an infection with H. pylori is diagnosed, timing plays a decisive role. The sooner it is detected, the better it can be treated.

ImevaX GmbH Videos

Helicobacter Pylori - Video

How to Use - Pylori DuoTect H. pylori Rapid Diagnostic Test - Video

Contact supplier